The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.
This recall involves bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain lot numbers. The recalled bottles have “Sandoz,” the name of the medication, dosage, and NDC on the front of the bottle labels and the lot number and expiration date on the side of the bottle labels. The recall includes the following:
|Recalled Prescription Drugs||NDC Numbers||Lot Numbers||Expiration Date|
|Ezetimibe 10mg Tablets||0781-5690-31||JE4491||Aug-2020|
|30 count bottle||JE4492||Aug-2020|
|Ezetimibe 10mg Tablets||0781-5690-92||JE4481||Aug-2020|
|90 count bottle||JG0249||Sep-2020|
|Losartan Potassium 50mg Tablets||0781-5701-31||HV9471||Feb-2020|
|30 count bottle|
Consumers should immediately secure the medications to keep them out of the sight and reach of children and contact Sandoz for a free replacement child resistant bottle cap. Once the medication is secured, consumers can continue to use the medication as directed.
The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risk of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product-related incidents cost the nation more than $1 trillion annually. CPSC's work to ensure the safety of consumer products has contributed to a decline in the rate of injuries associated with consumer products over the past 50 years.
Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.